California Public Employees Retirement System Makes New $58,000 Investment in Amyris Inc (NASDAQ:AMRS)

California Public Employees Retirement System purchased a new position in Amyris Inc (NASDAQ:AMRS) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 12,205 shares of the biotechnology company’s stock, valued at approximately $58,000.

Other institutional investors have also modified their holdings of the company. UBS Asset Management Americas Inc. bought a new stake in shares of Amyris during the 2nd quarter valued at $57,000. American Financial Advisors LLC raised its holdings in Amyris by 31.3% in the 2nd quarter. American Financial Advisors LLC now owns 21,000 shares of the biotechnology company’s stock worth $74,000 after purchasing an additional 5,000 shares during the period. Envestnet Asset Management Inc. bought a new position in Amyris in the 3rd quarter worth $114,000. River & Mercantile Asset Management LLP purchased a new position in Amyris during the second quarter valued at $126,000. Finally, D. E. Shaw & Co. Inc. purchased a new position in Amyris during the second quarter valued at $148,000. Institutional investors and hedge funds own 22.45% of the company’s stock.

AMRS has been the subject of a number of analyst reports. HC Wainwright restated a “buy” rating and issued a $11.00 price target on shares of Amyris in a research report on Friday, October 11th. BidaskClub raised Amyris from a “sell” rating to a “hold” rating in a research note on Tuesday, December 3rd.

Amyris stock opened at $3.24 on Friday. The firm has a 50 day moving average of $3.82 and a 200 day moving average of $3.77. The firm has a market capitalization of $341.83 million, a price-to-earnings ratio of -1.28 and a beta of 1.00. Amyris Inc has a 12-month low of $1.87 and a 12-month high of $6.06.

Amyris (NASDAQ:AMRS) last issued its quarterly earnings results on Monday, October 7th. The biotechnology company reported ($0.82) earnings per share for the quarter. The business had revenue of $14.37 million for the quarter. As a group, analysts predict that Amyris Inc will post -2.3 EPS for the current fiscal year.

Amyris Profile

Amyris, Inc, an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products.

Featured Story: How To Calculate Debt-to-Equity Ratio

Want to see what other hedge funds are holding AMRS? Visit to get the latest 13F filings and insider trades for Amyris Inc (NASDAQ:AMRS).

Institutional Ownership by Quarter for Amyris (NASDAQ:AMRS)

Receive News & Ratings for Amyris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris and related companies with's FREE daily email newsletter.